IMR Press / CEOG / Volume 43 / Issue 2 / DOI: 10.12891/ceog2040.2016

Clinical and Experimental Obstetrics & Gynecology (CEOG) is published by IMR Press from Volume 47 Issue 1 (2020). Previous articles were published by another publisher on a subscription basis, and they are hosted by IMR Press on imrpress.com as a courtesy and upon agreement with S.O.G.

Case Report
Peripartum cardiomyopathy: a case of patient with triplet pregnancy
Show Less
1 Clinic of Gynecology and Obstetrics, Clinical Center of Serbia, School of Medicine, University of Belgrade
1 Clinical Center of Serbia, School of Medicine, University of Belgrade, Belgrade
2 Clinic of Gynecology and Obstetrics, Clinical Center of Serbia, Belgrade
3 Clinic for Endocrinology, Diabetes and Metabolic Disorders
4 Cardiology Clinic, Clinical Center of Serbia, School of Medicine, University of Belgrade, Belgrade (Serbia)
Clin. Exp. Obstet. Gynecol. 2016, 43(2), 274–275; https://doi.org/10.12891/ceog2040.2016
Published: 10 April 2016
Abstract

Peripartum cardiomyopathy (PPCM) is a rare but potentially devastating complication of pregnancy associated with heart failure due to left ventricular systolic dysfunction occurring within the last month of pregnancy and five month postpartum with no obvious other cause of heart failure and no pre-existing heart disease. In the present case report the authors present a woman who developed PPCM on the day after she delivered by cesarean section in 35th weeks of gestation of triplet pregnancy conceived after ovarian stimulation and insemination. A treatment with diuretics, ACE inhibitors, antiarrhythmics, low weight heparin, antibiotics and bromocriptine was applied and resulted in complete recovery. In conclusion, timely detection and initiation of treatment are important factors for complete recovery of patients with PPCM.
Keywords
Heart failure
Peripartum cardiomyopathy
Infertility treatment
Share
Back to top